Post-Traumatic Stress Disorder

View All

Pharma News for BMS, Alnylam, MaaT Pharma
BMS’s LPA1 Antagonist; Alnylam’s KARDIA-1 Phase 2 Study; Day One Biopharma Sought FDA Approval for Tovorafenib; EMA Orphan Drug Designation to MaaT Pharma’s MaaT033; Lundbeck and Otsuka Announce Topline Results from Two Phase III Trials of Brexpiprazole + Sertraline; Phase III CheckMate – 227 Trial Show Durable, Long-Term Survival with Opdivo Plus Yervoy

Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase II Study BMS-986278, a potential first-in-class oral lysophosphatidic acid receptor 1 (LPA1) antagonist, was studied in patients with progressive pulmonary fibrosis (PPF)...

Find More

emerging-therapies-for-ptsd-treatment
Post-traumatic Stress Disorder (PTSD) Treatment: Will the Emerging Therapies Succeed in Curing this Invisible Wound?

Post-traumatic stress disorder (PTSD) is a disorder that affects a wide range of people and can be triggered by various traumatic events, despite its association with military veterans or active-duty service members. According to the Department of Veterans Affairs, approximately 12 million adults in the United Stat...

Find More

Digital Therapeutics in Mental Health and Neurological Disorders
Role of Digital Therapeutics (DTx) in Mental Health Management

Over the last decade, various technologies, after being evaluated rigorously, have exhibited competence in treating mental health by becoming an extension of the already present care models. Today, the patient or user can now download a clinical-grade app on the phone, tablet, or computer and use it as a reliable m...

Find More

PTSD
Post-Traumatic Stress Disorder Day

Post-Traumatic Stress Disorder Awareness Day, a day dedicated to increasing awareness regarding PTSD (Post Traumatic Stress Disorder). It is celebrated annually on 27 June. Post-Traumatic Stress Disorder (PTSD) is a seriously debilitating condition that can develop in a person who has experienced or witnessed a...

Find More

EMDR Therapy
EMDR Therapy- Is it really that good?

Eye Movement Desensitization and Reprocessing (EMDR) is a psychotherapy treatment or a psychological treatment method, developed by American clinical psychologist, Dr Francine Shapiro, in the 1980s. The therapy is a popular way of treatment used to recover from distressing and disturbing life experiences that resul...

Find More

enzymes FAAH
Fatty Acid Amide Hydrolase (FAAH) Inhibitor – an enzyme with novel therapeutic potential

Fatty acid amide hydrolase (FAAH) belongs to the serine hydrolase family of enzymes. The identification of this enzyme was led by the discovery and characterization of fatty acid amides, including anandamide and oleamide, as a fundamental class of endogenous signaling molecules. FAAH serves as the major metabolic re...

Find More